Lemmuel Lara Tayo

Lemmuel Lara Tayo

Auto-generated profile, based on publicly available information

Lemmuel Lara Tayo

School of Chemical, Biological, Materials Engineering and Sciences, Mapua University, Manila 1002, Philippines

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Aerosol and Air Quality Research
Verified
Journal Article
Open access
YHYi-Chyun Hsu
Yi-Chyun Hsu
RARachelle Anne D. Arcega
Rachelle Anne D. Arcega
YGYan-You Gou
Yan-You Gou
LTLemmuel L. Tayo
Lemmuel L. Tayo
Yi-Hsien LinYi-Hsien Lin
Yi-Hsien Lin
How-Ran ChaoHow-Ran Chao
How-Ran Chao
The international journal of Aerosol and Air Quality Research (AAQR) covers all aspects of aerosol science and technology, atmospheric science and air quality related issues.

13 October 2020 in Journal of Applied Microbiology
Verified
Journal Article
Open access
PDF file
CTChing‐Yi Tsai
Ching‐Yi Tsai
Shao-Yang HuShao-Yang Hu
Shao-Yang Hu
John Harvey SantosJohn Harvey Santos
John Harvey Santos
GCGail Everette M. Catulin
Gail Everette M. Catulin
LTLemmuel L. Tayo
Lemmuel L. Tayo
PKPin-Chuang Pin Kuo
Pin-Chuang Pin Kuo
Aims In this study, we aimed to isolate and evaluate the efficacy of Bacillus velezensis as a probiotic and to assess its activity towards pigeons infected with pigeon circovirus (PiCV). Methods and results B. velezensis, isolated from pigeon feces, was orally administered to pigeons for 60 d. After pigeons were challenged with PiCV, the PiCV viral load and expression of indicator genes for innate immunity were detected in spleen tissue and feces of pigeons. B. velezensis significantly reduced the PiCV viral load in the feces and spleen of pigeons 5 d post‐challenge (dpc). The mRNA expression levels of treated pigeons showed that interferon‐gamma (IFN‐γ), myxovirus resistance 1 (Mx1), and signal transducers and activators of transcription 1 (STAT1) genes were upregulated, whereas no expression of interleukin‐4 (IL‐4) was detected. Moreover, toll‐like receptor 2 (TLR2) and 4 (TLR4) were significantly upregulated in probiotic‐treated pigeons (p < 0.05). Conclusions This is the first report showing that probiotic supplementation can effectively enhance the T‐helper type 1 (Th1) immune response and decrease the PiCV viral loads in pigeons. Significance and impact of the study This study proposes that the administration of a probiotic strain, B. velezensis, to pigeons can protect against PiCV infection.

15 May 2015 in Journal of Applied Polymer Science
Verified
Journal Article
Closed access
PDF file
LTLemmuel L. Tayo
Lemmuel L. Tayo
Antoine VenaultAntoine Venault
Antoine Venault
VCVryan Gil R. Constantino
Vryan Gil R. Constantino
ACAlvin R. Caparanga
Alvin R. Caparanga
ACArunachalam Chinnathambi
Arunachalam Chinnathambi
Antoine VenaultAntoine Venault
Antoine Venault

19 October 2023 in Letters in Drug Design & Discovery
Verified
Journal Article
Closed access
PDF file
CRChristine Joyce Flores Rejano
Christine Joyce Flores Rejano
LTLemmuel L. Tayo
Lemmuel L. Tayo
BCBor-yann Chen
Bor-yann Chen
TSAI PO-WEITSAI PO-WEI
TSAI PO-WEI
Introduction: Parkinson’s disease (PD) is a prevalent neurological disease characterized by the gradual degeneration of dopaminergic neurons leading to a dysfunctional central nervous system. Recently, major metabolites of Coffea arabica leaves were revealed to exhibit good electronshuttling potential in Microbial Fuel Cells (MFCs), similar to neurotransmitters dopamine and epinephrine. Objective: This In silico study aimed to identify the neuroprotective potentials of plant metabolites from coffee leaves and to determine their physicochemical and pharmacokinetic properties for developing viable anti-parkinsonian drug design. Methods: Molecular docking was performed to evaluate the affinity of identified major compounds in C. arabica against PD-target proteins and compare the results with the binding activity of existing drugs and natural ligands of the identified protein targets via LibDock scores. The druglikeness and ADMET profiles of each ligand were also evaluated using bioinformatics tools. Results: C. arabica metabolites exhibited various degrees of binding activity against PD targets. LibDock scores of test compounds showed that catechin, mangiferin, and chlorogenic acid exhibited higher docking scores than dopamine and levodopa. Physicochemical and pharmacokinetics analysis of the selected molecules revealed caffeine, catechin, and chlorogenic acid as promising candidates for drug development with a low risk of drug toxicity. Conclusion: The present study indicates that Coffea arabica leaves contain promising neuroprotective active compounds against Parkinson’s disease.


19 October 2023 in Letters in Drug Design & Discovery
Verified
Journal Article
Closed access
PDF file
ZRZaina Allyson Abalos Rivera
Zaina Allyson Abalos Rivera
LTLemmuel L. Tayo
Lemmuel L. Tayo
BCBor-yann Chen
Bor-yann Chen
TSAI PO-WEITSAI PO-WEI
TSAI PO-WEI
Background: Parkinson’s Disease is one of the leading neurodegenerative disorders in the world. Currently, there is still no treatment that could completely cure the disease. Traditional Chinese Medicine has been a source for drug candidates, and many studies have elucidated its pharmacokinetic capabilities. Previous studies showed that Magnolia officinalis has anti-inflammatory, antioxidant, and bioenergy generation activities. Furthermore, the electron-shuttling and bioenergy-stimulating capabilities of herbal and brain disorder medicines have been linked to their effectiveness as a remedy. Objective: This preliminary study aims to evaluate the electron-shuttling compounds of Magnolia officinalis (i.e., acteoside, isoquercitrin, magnatriol B, obovatol, quercitrin, randaiol, and rutin) as potential drug candidates for Parkinson’s Disease. Methods: The seven electron-shuttling compounds were individually docked to the five Parkinson’s Disease-related proteins, namely aromatic L-amino acid decarboxylase, α-synuclein, monoamine oxidase B, catechol-o-methyltransferase, and A2A adenosine receptor, using LibDock. ADMET predictions were also made to screen the compounds further. Results: Molecular docking results showed that all compounds have relatively high LibDock scores against the proteins, with acteoside, isoquercitrin, and rutin having the highest scores. However, considering the ADMET results, only magnatriol B, obovatol, and randaiol had optimal properties as candidates for neurodegenerative drugs. Conclusion: The electron-shuttling compounds of M. officinalis, magnatriol B, obovatol, and randaiol, have the potential to be a remedy for Parkinson’s Disease due to their high probability of binding to the proteins.